Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Design and Synthesis of Photodissociable Ligands Based on Azoimidazoles for Light-Driven Coordination-Induced Spin State Switching in Homogeneous Solution.

The Journal of organic chemistry

Schütt C, Heitmann G, Wendler T, Krahwinkel B, Herges R.
PMID: 26761623
J Org Chem. 2016 Feb 05;81(3):1206-15. doi: 10.1021/acs.joc.5b02817. Epub 2016 Jan 27.

Light-switchable azoimidazoles were rationally designed and synthesized, and their performance was investigated as photodissociable ligands (PDL) and for spin state switching of Ni porphyrins. The rationally designed ligands exhibit a high photochemical conversion rate (trans → cis > 98%)...

Cite
Schütt C, Heitmann G, Wendler T, et al. Design and Synthesis of Photodissociable Ligands Based on Azoimidazoles for Light-Driven Coordination-Induced Spin State Switching in Homogeneous Solution. J Org Chem. 2016;81(3):1206-15doi: 10.1021/acs.joc.5b02817.
Schütt, C., Heitmann, G., Wendler, T., Krahwinkel, B., & Herges, R. (2016). Design and Synthesis of Photodissociable Ligands Based on Azoimidazoles for Light-Driven Coordination-Induced Spin State Switching in Homogeneous Solution. The Journal of organic chemistry, 81(3), 1206-15. https://doi.org/10.1021/acs.joc.5b02817
Schütt, Christian, et al. "Design and Synthesis of Photodissociable Ligands Based on Azoimidazoles for Light-Driven Coordination-Induced Spin State Switching in Homogeneous Solution." The Journal of organic chemistry vol. 81,3 (2016): 1206-15. doi: https://doi.org/10.1021/acs.joc.5b02817
Schütt C, Heitmann G, Wendler T, Krahwinkel B, Herges R. Design and Synthesis of Photodissociable Ligands Based on Azoimidazoles for Light-Driven Coordination-Induced Spin State Switching in Homogeneous Solution. J Org Chem. 2016 Feb 05;81(3):1206-15. doi: 10.1021/acs.joc.5b02817. Epub 2016 Jan 27. PMID: 26761623.
Copy Download .nbib Format: NLM
Gold Nanoparticle-Mediated Delivery of Molecules into Primary Human Gingival Fibroblasts Using ns-Laser Pulses: A Pilot Study.

Materials (Basel, Switzerland)

Krawinkel J, Torres-Mapa ML, Werelius K, Heisterkamp A, Rüttermann S, Romanos GE, Gerhardt-Szép S.
PMID: 28773519
Materials (Basel). 2016 May 20;9(5). doi: 10.3390/ma9050397.

Interaction of gold nanoparticles (AuNPs) in the vicinity of cells' membrane with a pulsed laser (λ = 532 nm, τ = 1 ns) leads to perforation of the cell membrane, thereby allowing extracellular molecules to diffuse into the cell....

Cite
Krawinkel J, Torres-Mapa ML, Werelius K, et al. Gold Nanoparticle-Mediated Delivery of Molecules into Primary Human Gingival Fibroblasts Using ns-Laser Pulses: A Pilot Study. Materials (Basel). 2016;9(5)doi: 10.3390/ma9050397.
Krawinkel, J., Torres-Mapa, M. L., Werelius, K., Heisterkamp, A., Rüttermann, S., Romanos, G. E., & Gerhardt-Szép, S. (2016). Gold Nanoparticle-Mediated Delivery of Molecules into Primary Human Gingival Fibroblasts Using ns-Laser Pulses: A Pilot Study. Materials (Basel, Switzerland), 9(5), . https://doi.org/10.3390/ma9050397
Krawinkel, Judith, et al. "Gold Nanoparticle-Mediated Delivery of Molecules into Primary Human Gingival Fibroblasts Using ns-Laser Pulses: A Pilot Study." Materials (Basel, Switzerland) vol. 9,5 (2016). doi: https://doi.org/10.3390/ma9050397
Krawinkel J, Torres-Mapa ML, Werelius K, Heisterkamp A, Rüttermann S, Romanos GE, Gerhardt-Szép S. Gold Nanoparticle-Mediated Delivery of Molecules into Primary Human Gingival Fibroblasts Using ns-Laser Pulses: A Pilot Study. Materials (Basel). 2016 May 20;9(5). doi: 10.3390/ma9050397. PMID: 28773519; PMCID: PMC5503001.
Copy Download .nbib Format: NLM
Prevention of the decrease in sensitivity of an amperometric glucose sensor in undiluted human serum .

Clinical chemistry

Kerner W, Kiwit M, Krahwinkel M, Linke B, Thomas K.
PMID: 9931053
Clin Chem. 1999 Feb;45(2):283-5.

No abstract available.

Cite
Kerner W, Kiwit M, Krahwinkel M, et al. Prevention of the decrease in sensitivity of an amperometric glucose sensor in undiluted human serum . Clin Chem. 1999;45(2):283-5
Kerner, W., Kiwit, M., Krahwinkel, M., Linke, B., & Thomas, K. (1999). Prevention of the decrease in sensitivity of an amperometric glucose sensor in undiluted human serum . Clinical chemistry, 45(2), 283-5.
Kerner, et al. "Prevention of the decrease in sensitivity of an amperometric glucose sensor in undiluted human serum ." Clinical chemistry vol. 45,2 (1999): 283-5.
Kerner W, Kiwit M, Krahwinkel M, Linke B, Thomas K. Prevention of the decrease in sensitivity of an amperometric glucose sensor in undiluted human serum . Clin Chem. 1999 Feb;45(2):283-5. PMID: 9931053.
Copy Download .nbib Format: NLM
Evaluation of the Pharmacokinetic Interaction Between the β3 -Adrenoceptor Agonist Mirabegron and the Muscarinic Receptor Antagonist Solifenacin In Healthy Subjects.

Clinical pharmacology in drug development

Krauwinkel WJ, Kerbusch VM, Meijer J, Tretter R, Strabach G, Van Gelderen EM.
PMID: 27121787
Clin Pharmacol Drug Dev. 2013 Jul;2(3):255-63. doi: 10.1002/cpdd.37. Epub 2013 May 14.

Mirabegron, a selective β3 -adrenoceptor agonist, is approved for the treatment of overactive bladder (OAB). Solifenacin is a muscarinic receptor antagonist widely used in the treatment of OAB. This open-label, 1-sequence, 2-arm study investigated whether any pharmacokinetic interaction exists...

Cite
Krauwinkel WJ, Kerbusch VM, Meijer J, et al. Evaluation of the Pharmacokinetic Interaction Between the β3 -Adrenoceptor Agonist Mirabegron and the Muscarinic Receptor Antagonist Solifenacin In Healthy Subjects. Clin Pharmacol Drug Dev. 2013;2(3):255-63doi: 10.1002/cpdd.37.
Krauwinkel, W. J., Kerbusch, V. M., Meijer, J., Tretter, R., Strabach, G., & Van Gelderen, E. M. (2013). Evaluation of the Pharmacokinetic Interaction Between the β3 -Adrenoceptor Agonist Mirabegron and the Muscarinic Receptor Antagonist Solifenacin In Healthy Subjects. Clinical pharmacology in drug development, 2(3), 255-63. https://doi.org/10.1002/cpdd.37
Krauwinkel, Walter J J, et al. "Evaluation of the Pharmacokinetic Interaction Between the β3 -Adrenoceptor Agonist Mirabegron and the Muscarinic Receptor Antagonist Solifenacin In Healthy Subjects." Clinical pharmacology in drug development vol. 2,3 (2013): 255-63. doi: https://doi.org/10.1002/cpdd.37
Krauwinkel WJ, Kerbusch VM, Meijer J, Tretter R, Strabach G, Van Gelderen EM. Evaluation of the Pharmacokinetic Interaction Between the β3 -Adrenoceptor Agonist Mirabegron and the Muscarinic Receptor Antagonist Solifenacin In Healthy Subjects. Clin Pharmacol Drug Dev. 2013 Jul;2(3):255-63. doi: 10.1002/cpdd.37. Epub 2013 May 14. PMID: 27121787.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries